Background: Phakic intraocular lenses (IOL) are being used to correct refractive errors. We studied the pattern of increasing Intraocular Pressure (IOP) after Phakic Anterior chamber intraocular lens implantation as the risk after surgery. Methods: Sixty eyes of 30 patients were enrolled. All eyes underwent the same protocol with IOP examination before surgical procedure, and during follow up (one day after, 2 weeks, 1 month, 2 months and 3 months) after implantation of phakic IOL anterior chamber. All results were analyzed statistically using SPSS 16 statistics software. Correlation between parameter were analyzed using the wilcoxon test. Results: Median IOP before surgery were 14.00 mmHg (IOP), during follow up 17.00 mmHg (IOP I), 16.00 mmHg (IOP II) , 17.00 mmHg (IOP III), 15.00 mmHg (IOP IV), 15.00 mmHg (IOP V). The increasing of IOP between pre surgery and follow up a day after was found to correlate significantly (p=0.03), there were increasing of IOP after 2 weeks, a month, 2 and 3 months but no significant difference. Conclusion: There were significant of increasing IOP before surgery compare to a day after surgery,then the pattern of increasing IOP tend to be stable. There were no significant increasing of IOP during 3 months follow up.
P hakic intraocular lenses (PIOL) are clear implantable lenses that are surgically placed either in anterior chamber (AC) or posterior chamber (PC) without removing the natural lens, enabling light to focus on the retina for improved uncorrected visual acuity. 1, 2 Photorefractive keratectomy and LASIK may have limitations when used for the correction of high refractive errors. Wound healing and biomechanical responses can occasionally lead to poor refractive predictability, prolonged visual recovery, instability of refraction, and loss of vision from corneal irregularity or scarring. Removing too much corneal tissue with the laser can induce progressive ectasia. [2] [3] Two basic intraocular refractive procedures exist: phakic intraocular lens (PIOL) implantation and clear lens extraction with lens implantation, also called refractive lens exchange. The iris-fixated lens, on the other hand, is stabilized further from the camerular angle, corneal endothelium and crystalline lens, being the most implanted pIOL ORIGINAL ARTICLE today. Another advantage is optical: the claw principle guarantees centering of the lens over the pupil, and rotational stability, which is especially important for toric lenses. 3 The risks and benefits of pIOL implantation in appropriate patients may be more favorable than other refractive surgery techniques. The pIOL is removable surgically, Visual recovery is fast, and accommodation is preserved, Implantation of a pIOL utilizes operative techniques familiar to most cataract surgeons and does not require expensive or specialized devices. [3] [4] Complications relating to pIOLs can be more disabling than those from keratorefractive surgery. Potential complications following implantation of phakic intraocular lenses include The main complications of irisfixated anterior chamber pIOLs are chronic subclinical inflammation, corneal endothelial cell loss, cataract formation, secondary glaucoma, iris atrophy and dislocation. [3] [4] [5] A variety of causes have been implicated in case reports of high IOP after phakic intraocular lens implantation. Raised IOP following implantation can be seen in the early or late post operative period. The rate of occurrence of raised IOP as reported in literature ranges from 0.8% to 26.2%. We studied the pattern of increasing Intraocular Pressure (IOP) after Phakic Anterior chamber intraocular lens implantation (Artisan®/Artiflex®) phakic intraocular lenses (pIOLs) as a complication after surgery that may lead to secondary glaucoma. [4] [5] 
METHOD
In all, 60 eyes of 30 patients had surgeries at the YAP Eye Hospital, Jogjakarta Indonesia, from January to December 2016. All of the patients were fully informed about the details of the procedures and the risks involved, and were given informed consents to sign. Patient´s age and gender were recorded. Inclusion criteria: (1) Stable refraction (less than 0.5D change for 1 year); (2) clear crystalline lens; (3) ametropia not appropriate for excimer laser surgery; (4) unsatisfactory vision with contact lenses or spectacles; (5) appropriate pupil size for the specified PIOL; (6) adequate anterior chamber depth (ACD); (7) minimum endothelial cell count (ECC); Exclusion criteria: Subjects with (1) anisometropia; (2) anterior segment pathology; (3) inadequate eyelid closure; (4) ECC <1800 cells/ mm 2 ; (5) central ACD <3.0 mm; (6) abnormal iris or pupil function; (7) intraocular pressure (IOP) >21 mm Hg; (8) previous corneal or intraocular surgery; (9) any intraocular eye disease such as recurrent or chronic uveitis, cataract, glaucoma, or family history of glaucoma, retinal detachment or family history of retinal detachment, preexisting macular degeneration or macular pathology; (10) systemic diseases, chronic treatment with corticosteroids or any immunosuppressive treatment or state, and pregnancy. Patients with raised IOP were identified using the following criteria: IOP elevation equal to or greater than 21 mmHg, in this study we describe the pattern of IOP by 1 day, 2 weeks, 1 month, 2 months and 3 months period of follow up.
SURGICAL TECHNIQUE
Thirty minutes before the operation, the mitotic drop (1% pilocarpine) was given every 5 min, 3 times, then topical anesthetic was given three times. A superior sclerocorneal self-sealing 5.3-mm to 5.5-mm incision and two paracenteses were created. A cohesive ophthalmic viscosurgical device (sodium hyaluronate 1%) was injected through the paracenteses to maintain ACD and protect endothelial cells. Further, the IOL was placed into the anterior chamber and was enclavated onto the iris, after which the visco surgical device was removed. All eyes underwent a peripheral iridotomy during the operation.
All subjects underwent a comprehensive preoperative evaluation at YAP Eye Specialist Hospital. IOP was measured primarily with a Non Contact Tonometer at one day, 2 weeks, 1 month, 2 months and 3 months post-operation.
The primary outcome measure was intraocular pressure during the period of follow up.
Statistical analysis was performed on the intent to treat basis using SPSS version 16 software. The 95% confidence interval (CI) values were calculated for each mean. A value <0.05 was considered statistically significant.
RESULTS
A total of 8 (13.3 %) myopic eyes that underwent iris-fixated iol implantation developed elevated IOP on the first postoperative day. The following amount of eyes developed elevated IOP within respective time periods: 1 eye wihin 2 weeks, 7 eyes within 1 month, and 4 eyes after 3 months. Demographic data and baseline characteristics of the study patients are presented in Table 1 . Most patients were male 16 (53.3%) and female 14 (46.7%) and the age mean was 22.5±5. Preoperatively,The median preoperative IOP was 14.00 ± 3.44 mmHg (range 6-21 mmHg). None of the eyes had a history of elevated IOP or documentation of IOP elevation preoperatively.
There were increasing of IOP at day 1 after surgical and 1 month after. Then we correlate the increasing of IOP during follow up and the IOP pre operatif as the control. IOP day 1 (IOP I), IOP 2 weeks (IOP II), IOP 1 month (IOP III), IOP 2 month (IOP IV) and IOP 3 month (IOP V). We correlate the increasing of IOP between pre surgery (IOP) and IOP After term of follow up by Using Wilcoxon Test. There was significantly increasing of IOP between pre surgery and the day after surgery with p<0.003. 
DISCUSSION
The Iris Fixated lens pIOL rarely can induce glaucoma compare with the angle supported IOL. The iris-fixated anterior IOL was fixated on the iris, avoiding the trabecular meshwork damage. [5] [6] [7] Preoperative iridotomy or an intraoperative iridectomy can avoid the pupil block, and thus, in this study, all eyes underwent peripheral iridotomy during the operation. Transitory increase in IOP after operation after surgery was observed, possible mechanisms of raised IOP in this study, first due to Retained viscoelastic or overfill of the anterior chamber presents in the immediate postoperative period and often resolves with short course of antiglaucoma and anti-inflammatory medications. Second due to steroidal eye drops, Steroid induced IOP rise is reported as one of the commonest causes of elevated IOP following phakic IOL implantation, occurring within 1-4 weeks.
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There were 4 eyes with persistent raise of IOP during the 3 months follow-up. It was later found due to the possibility of chronic inflammation.
Pupillary block can also occur in patients with anterior chamber IOLs, either by direct blockage by the optic or by the adhesions between vitreous and posterior iris, but none was observed in this study [9] [10] [11] . The increased IOP between pre surgery (IOP) and the follow-up a day after(IOP I), 2 weeks (IOP II), a month (IOP III), 2 months (IOP IV) and 3 months (IOP V) were correlated using Wilcoxon Test.
There was a significant increase of IOP between pre-surgery and the day after surgery with p<0.003. It was shown that the increase in IOP only occurred after Iris fixated IOL at day 1 post-surgery. Due to the retaining property of the viscoelastics, in this study we used sodium hyaluronate 1% as viscoelastic. The literature showed that Elevated IOP was due to retained viscoelastics that is more common in high viscous ocular viscoelastic devices (OVD) like Sodium hyaluronate in comparison to hydroxyl propyl methyl cellulose (HPMC). In a series by Almalki et al, retained OVD was responsible for elevated IOP in the majority of the cases (39.7%) followed by the steroid response (37.9% eyes). Irrigating out the viscoelastic instead of irrigation and aspiration was one of the reasons for increased incidence of retained viscoelastic and high IOP in their series. However, the IOP was normalized with short term Anti-Glaucoma Medication, without the need for long term medication for IOP control. 3, 11 
CONCLUSION
There was a significant increase in IOP before surgery in comparison to a day after surgery. After which, the pattern tends to be stable. There was no significant increase in IOP during 3 months of follow-up. Our data demonstrated that the iris-fixated pIOL implantation is a safe and predictable option in reversible procedure for high myopia treatment and it is an effective of refractive surgery. 
